Articles From: Amicus Therapeutics Provides Full-Year 2014 Strategic Outlook and Financial Guidance to Amira Nature Foods Ltd Provides Update on Indian Rice Crop Planting Progress


2014/1/13
3 Next-Generation Enzyme Replacement Therapies (ERTs) Expected to Enter Clinic in Next 3 Years, Beginning in 2014 FY14 Cash Spend Guidance of $54-$59 Million — Current Cash Expected to Fund Operations Into 2H15 CRANBURY, N.J., Jan.
Sign-up for Amicus Therapeutics Provides Full-Year 2014 Strategic Outlook and Financial Guidance investment picks
Callidus Biopharma Acquisition Adds Next-Generation Pompe ERT and Enzyme Technology Platform Revised Agreement with GSK Provides Global Development & Commercial Rights to Next-Generation Fabry ERT Company Funded into Late 2015 with $40 Million in Equity and Expected Debt Financing Conference Call Today at 5:00 p.m. ET CRANBURY, N.J., Nov.
Sign-up for Amicus Therapeutics Strengthens Biologics Business Strategy investment picks
2014/2/26
CRANBURY, N.J., Feb.
Sign-up for Amicus Therapeutics to Announce Full-Year 2013 Financial Results on March 3, 2014 investment picks
CRANBURY, N.J., Aug.
Sign-up for Amicus Therapeutics to Announce Second Quarter 2013 Financial Results on August 7, 2013 investment picks
2014/3/27
CRANBURY, N.J., March 27, 2014 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD) , a biopharmaceutical company at the forefront of developing therapies for rare and orphan diseases, today announced that John F.
Sign-up for Amicus Therapeutics to Present at 13th Annual Needham Healthcare Conference investment picks
2014/2/11
CRANBURY, N.J., Feb.
Sign-up for Amicus Therapeutics to Present at 2014 Leerink Global Healthcare Conference investment picks
2014/1/10
CRANBURY, N.J., Jan.
Sign-up for Amicus Therapeutics to Present at 32nd Annual J.P. Morgan Healthcare Conference investment picks
2014/2/27
CRANBURY, N.J., Feb.
Sign-up for Amicus Therapeutics to Present at Cowen and Company 34th Annual Health Care Conference investment picks
CRANBURY, N.J., Sept.
Sign-up for Amicus Therapeutics to Present at Leerink Swann Rare Disease Roundtable investment picks
2013/9/5
CRANBURY, N.J., Sept.
Sign-up for Amicus Therapeutics to Present at Stifel Nicolaus 2013 Healthcare Conference investment picks
2013/8/8
CRANBURY, N.J., Aug.
Sign-up for Amicus Therapeutics to Present at Two August Investor Conferences investment picks
2014/2/27
ADVISORY, Feb.
Sign-up for Amicus Therapeutics, Inc. [FOLD] to Ring The NASDAQ Stock Market Closing Bell investment picks
Speaking at Research!America National Health Research Forum with FDA Commissioner Hamburg CRANBURY, N.J., Sept.
Sign-up for Amicus Therapeutics' CEO John F. Crowley to Advocate for Rare and Orphan Disease Community in Washington, D.C. This Week investment picks
By John Kell Amicus Therapeutics Inc. (FOLD) intends to trim costs by cutting 14% of its work force, while the biopharmaceutical company said it revised the terms of a pact with GlaxoSmithKline PLC (GSK, GSK.LN) and acquired a firm.
Sign-up for Amicus to Trim Jobs, Revises GlaxoSmithKline Pact Terms investment picks
U.S. executives at large companies confirm that a skills gap persists for their businesses, with nearly half (46 percent) concerned that they won’t have the skills they need in the next one to two years, according to new research released today by Accenture (NYSE:ACN). In a positive sign, 51 percent of companies expect to increase investments in training over the next two years, and 35 percent of executives whose companies are facing a skills shortage admitted that they have not invested enough in training in the past.
Sign-up for Amid Anticipated Skills Shortages, Half of U.S. Businesses Plan to Increase their Investment in Training in the Next Two Years, Accenture Research Finds investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1043939&ProfileId=051205&sourceType=1 LOS ANGELES, CA --
Sign-up for Amiga Games Inc., a Newly Acquired Company of Writers Group Film Corp., Announces Classic Game Co-Marketing and Distribution Agreement With Microsoft Corporation investment picks
2014/2/6
Amira Nature Foods Ltd (the "Company") (NYSE: ANFI), a leading global provider of packaged Indian specialty rice, today announced that it entered into a $58.6 million contract to supply third party branded basmati rice to a key repeat customer in the Europe, Middle East, and Africa (“EMEA”) region.
Sign-up for Amira Nature Foods Ltd Announces $58.6 Million Contract with Repeat Customer investment picks
2013/11/11
Amira Nature Foods Ltd (the "Company") (NYSE: ANFI), a leading global provider of packaged Indian specialty rice, today announced the appointment of Harash Pal Sethi to the Company’s Board of Directors, effective November 10, 2013.
Sign-up for Amira Nature Foods Ltd Announces Appointment of New Independent Board Member investment picks
2014/3/31
Amira Nature Foods Ltd (the “Company”) (NYSE: ANFI), a leading global provider of packaged Indian specialty rice, announced the distribution of Amira branded products in Heritage Retail stores.
Sign-up for Amira Nature Foods Ltd Announces Distribution of Amira Branded Products in Heritage Retail investment picks
2013/8/8
Amira Nature Foods Ltd (the "Company;" or “Amira”) (NYSE: ANFI) , a leading global provider of packaged Indian specialty rice, will release its first quarter 2014 financial results on Monday, August 26, 2013, after market close.
Sign-up for Amira Nature Foods Ltd Announces First Quarter 2014 Earnings Release Date and Conference Call investment picks
Amira Nature Foods Ltd (the "Company") (NYSE: ANFI) , a leading global provider of packaged Indian specialty rice, today reported financial results for the first quarter ended June 30, 2013.
Sign-up for Amira Nature Foods Ltd Announces First Quarter Fiscal 2014 Financial Results investment picks
2013/12/16
Amira Nature Foods Ltd (the "Company") (NYSE: ANFI), a leading global provider of packaged Indian specialty rice, announced that it has launched its Amira branded products in Reliance Retail Limited (“RRL”) stores.
Sign-up for Amira Nature Foods Ltd Announces Launch of Amira Branded Products in Reliance Retail Limited investment picks
Amira Nature Foods Ltd (the "Company;" or “Amira”) (NYSE: ANFI), a leading global provider of packaged Indian specialty rice, will release its second quarter 2014 financial results on Monday, November 11, 2013, after market close.
Sign-up for Amira Nature Foods Ltd Announces Second Quarter 2014 Earnings Release Date and Conference Call investment picks
2013/11/11
Amira Nature Foods Ltd (the "Company") (NYSE: ANFI), a leading global provider of packaged Indian specialty rice, today reported financial results for the second quarter and six months ended September 30, 2013.
Sign-up for Amira Nature Foods Ltd Announces Second Quarter Fiscal 2014 Financial Results investment picks
Amira Nature Foods Ltd(the "Company;" NYSE: ANFI), a leading global provider of packaged Indian specialty rice, today announced a definitive agreement to acquire Basmati Rice GmbH, a specialty distributer of premium branded rice, particularly Basmati rice in Germany.
Sign-up for Amira Nature Foods Ltd Announces Strategic Acquisition in Germany investment picks
2014/2/19
Amira Nature Foods Ltd (the "Company;" or “Amira”) (NYSE: ANFI), a leading global provider of packaged Indian specialty rice, will release its third quarter 2014 financial results on Tuesday, February 25, 2014, before market open.
Sign-up for Amira Nature Foods Ltd Announces Third Quarter 2014 Earnings Release Date and Conference Call investment picks
2014/2/25
Amira Nature Foods Ltd (the "Company;" NYSE:ANFI), a leading global provider of packaged Indian specialty rice, today reported financial results for the third quarter and nine months ended December 31, 2013.
Sign-up for Amira Nature Foods Ltd Announces Third Quarter Fiscal 2014 Financial Results investment picks
2014/1/30
Amira Nature Foods Ltd (the "Company") (NYSE: ANFI), a leading global provider of packaged Indian specialty rice, today closed the previously announced acquisition of Basmati Rice GmbH, a specialty distributor of premium branded rice, particularly Basmati rice in Germany.
Sign-up for Amira Nature Foods Ltd Closes Strategic Acquisition in Germany investment picks
Amira Nature Foods Ltd (the "Company")  (NYSE: ANFI) , a leading global provider of packaged Indian specialty rice, today announced an update on India’s commercial rice crop planting progress.
Sign-up for Amira Nature Foods Ltd Provides Update on Indian Rice Crop Planting Progress investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Amicus Therapeutics Provides Full-Year 2014 Strategic Outlook and Financial Guidance to Amira Nature Foods Ltd Provides Update on Indian Rice Crop Planting Progress
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity